We are experts in antipsychotic medication management!

Centers for Medicare & Medicaid (CMS) has announced sweeping changes in the way facilities are evaluated.

Effective immediately, the revamped assessments include a measure of a facility’s use of antipsychotic drugs which can pose serious risks for the elderly, especially those with dementia. Facilities looking to maintain or improve their quality ratings will need to enhance their management of psychiatric care, and MedOptions Behavioral Health can provide these services:

Our multi-disciplinary team of Psychiatrists, Nurse Practitioners, Psychologists and Licensed Clinical Social Workers will work collaboratively with your clinical team integrating both pharmacological and non-pharmacological interventions. Emphasis is on the assessment and understanding of the origin of the behavior with non-pharmacological interventions as the first line of treatment when possible.

Medication management team assists facilities to be compliant with F-tag 329 guidelines around Gradual Dose Reduction (GDR) of psychotropic medications.

Behavioral Rounds to assist facilities with the management of residents with challenging behaviors, especially in dementia.

 Partner with MedOptions to manage your antipsychotic usage to avoid being one of the 61% of facilities that will see a decline in their quality indicators as reported by USA Today’s article: “Nursing home quality scores drop in new federal ratings,” which can be viewed by clicking the link.

The USA Today video “Feds toughen nursing home ratings, thousands of facilities get lower scores” can also be viewed by clicking this link.

To view, and print or save, our PDF Flyer of this announcement click here.